Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 22 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
15 Aug 2025
EVP & CFO
Bought
715
$494.63K
5.1%
13 Aug 2025
EVP & Pres., Lilly Oncology
Bought
1,000
$647.36K
5.1%
13 Aug 2025
Director indirect
Bought
758
$500.47K
opened
12 Aug 2025
President, Chair, and CEO
Bought
1,632
$1.05M
0.3%
12 Aug 2025
Director
Bought
1,565
$1.01M
2.1%
12 Aug 2025
EVP, CSO & Pres. LRL & LLY Imm
Bought
1,000
$634.41K
0.7%
12 Aug 2025
Director
Bought
117
$75.02K
4.5%
8 Aug 2025
Director
Bought
200
$127.91K
2.2%
12 Aug 2022
Director
Bought
656
$199.55K
1.1%
1 Mar 2022
Director
Bought
202
$49.85K
1.3%
30 Apr 2021
Director
Bought
1,366
$249.76K
2.3%
25 Oct 2019
SVP, CSO, and Pres. LRL
Bought
5,000
$543.05K
7.1%
25 Oct 2019
President & CEO
Bought
4,615
$500.17K
3.0%
25 Oct 2019
SVP & Pres-Lilly Oncology
Bought
1,000
$108.84K
4.8%
25 Oct 2019
SVP and CFO
Bought
929
$99.95K
3.0%
24 Oct 2019
Director
Bought
1,861
$200.04K
3.4%
15 Jul 2019
SVP and CFO
Bought
185
$20.07K
0.6%
5 Jun 2019
SVP and CFO
Bought
426
$50.28K
1.4%
26 Jul 2018
Director
Bought
2,168
$206.44K
4.2%
14 Jun 2018
SVP, CSO, and Pres. LRL
Bought
10,000
$862.20K
22.1%
16 Dec 2016
Director
Bought
1,375
$99.88K
2.9%
16 Dec 2016
Director indirect
Bought
500
$35.93K
50.0%
Showing 1–22 of 22.